Open AccessMycoplasma as one of causal factors of exacerbation of community-acquired pneumonia
Author(s) -
F. V. Shirinova,
F. V. Shirinova
Publication year - 2021
Publication title -
permskij medicinskij žurnal
Language(s) - English
Resource type - Journals
eISSN - 2687-1408
pISSN - 0136-1449
DOI - 10.17816/pmj3755-11
Subject(s) - medicine , sputum , pneumonia , community acquired pneumonia , mycoplasma hominis , concomitant , exacerbation , mycoplasma pneumonia , mycoplasma pneumoniae , mycoplasma , etiology , immunology , intensive care medicine , tuberculosis , pathology , microbiology and biotechnology , biology
Objective. To improve the effectiveness of treatment in exacerbation of community-acquired pneumonia among military recruits with chronic inflammatory respiratory tract processes.
Materials and methods. The study included the data from 266 medical histories of military recruits aged 18-26, who had community-acquired pneumonia confirmed clinically and X-ray, as well as concomitant chronic respiratory diseases and a spectrum of isolated microorganisms in the sputum. When pneumonia worsened in patients who were admitted to the hospital, the level of blood serum antibodies to M. hominis was measured.
Results. The study results showed that in military recruits, suffering from community-acquired pneumonia with concomitant chronic respiratory diseases, in case of undetected microorganisms in the sputum, the measurement of blood serum IgM antibodies to Mycoplasma hominis has a clinical value.
Conclusions. Mycoplasma hominis occupies a special place in the etiological structure of pathology among patients with community-acquired pneumonia.